Synergistic inhibition of melanoma xenografts by Brequinar sodium and Doxorubicin. (Record no. 29073022)

MARC details
000 -LEADER
fixed length control field 01514 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518010818.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201904s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1950-6007
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.biopha.2018.11.010
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Dorasamy, Mathura Subangari
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190418
245 00 - TITLE STATEMENT
Title Synergistic inhibition of melanoma xenografts by Brequinar sodium and Doxorubicin.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Date of publication, distribution, etc. Feb 2019
300 ## - PHYSICAL DESCRIPTION
Extent 29-36 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biphenyl Compounds
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Doxorubicin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Synergism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Melanoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice, Nude
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Burden
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Xenograft Model Antitumor Assays
General subdivision methods
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ab, Aravind
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nellore, Kavitha
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wong, Pooi-Fong
773 0# - HOST ITEM ENTRY
Title Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Related parts vol. 110
-- p. 29-36
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.biopha.2018.11.010">https://doi.org/10.1016/j.biopha.2018.11.010</a>
Public note Available from publisher's website

No items available.